MDS and PRCA represent the diseases of inefficient erythropoiesis [37,38] and have been classically defined by the increased coefficient of variation (CV) of CD36 and CD71 expression on the erythroid precursor. The gene discussed is TFRC; the disease is myelodysplastic syndrome.